Fresenius Kabi USA LLC

10/17/2024 | Press release | Distributed by Public on 10/17/2024 09:12

Fresenius Kabi Inducts 12 into National Blood Donation Hall of Fame

Fresenius Kabi Inducts 12 into National Blood Donation Hall of Fame

October 17, 2024

Honorees recognized for their dedication to blood donation

LAKE ZURICH, Ill., October 17, 2024 - Fresenius Kabi, an operating company of Fresenius, today named 12 new inductees into the National Blood Donation Hall of Fame. Nominated by blood centers across the U.S., the honorees were chosen for their extraordinary commitment to donating blood or for encouraging blood donation.

Many of this year's inductees were initially inspired to donate blood or organize a blood drive after a friend or family member received a life-saving blood donation. Others became donors to honor the memory of loved ones, and still others give blood to build connections within their community. All of them have made a significant commitment to blood donation in their lives. This year's honorees join more than 300 prior honorees inducted into the Fresenius Kabi National Blood Donation Hall of Fame in the last 26 years.

This year's inductees include:

  • A 94-year-old woman who has organized hundreds of blood drives in her community for more than 50 years.
  • A man who drives 256 miles every two weeks to give blood and to date has made 1,100 donations - more than 330 gallons. His yellow Labrador retriever also donates to a local veterinary blood bank to help ensure injured animals have the blood they need.
  • A retired donor who has volunteered 4,300 hours and driven 156,000 miles to ensure blood products are available throughout the region where he lives.

"Giving blood is lifesaving work-a single donation can save multiple lives," said Eddie Kubo, senior vice president of commercial operations in North America and China for Fresenius Kabi's MedTech business that makes advanced blood-transfusion technologies. "This year's honorees have helped save countless lives, and we honor and celebrate them for their enduring and incredible commitment."

The 2024 inductees and their nominating blood centers are:

  • SUSAN MALLOY - American Red Cross, Greater Pennsylvania Region, Northeastern Pennsylvania District
  • JASPER SMITH - American Red Cross Blood Donation Center, Oakland, California
  • ROBERT HUNGERSCHAFER -American Red Cross, Vancouver, Washington Donor Center
  • J. DAVID MYERS -Blood Bank of Delmarva, Newark, Delaware
  • ANA CRUZ HOLLINGSWORTH -Carter BloodCare, Bedford, Texas
  • MONTE ENGH -LifeServe Blood Center, Johnston, Iowa
  • ALEJANDRO HERRERA -OneBlood South Miami, Florida Facility
  • HUSTON OCHOA -OneBlood Ft. Lauderdale Commercial, Ft. Lauderdale, Florida
  • RAY LEBRON -San Diego Blood Bank, San Diego, California
  • JUDITH LAMUSGA -Solvita Blood Center, Dayton, Ohio
  • THE FONTANEZ FAMILY -Versiti Blood Center of Illinois
  • BERTHA AXTMAN -Vitalant, Minot, North Dakota

National Blood Donation Hall of Fame inductees are featured in an annual calendar used by blood centers that highlights the stories about their contributions to this important cause. To read about the 2024 inductees please visit, National Blood Donation Hall of Fame. To find a blood donation center, visit DonatingBlood.org.

About Fresenius Kabi

As a global health care company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients' nutritional status - notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.

Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication - making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders - shaping the future of health care.

Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale.

For more information, please visit www.fresenius-kabi.com.

Management Board: Pierluigi Antonelli (Chairman), Marc Crouton, Andreas Duenkel, Dr. Christian Hauer, Dr. Marc-Alexander Mahl, Dr. Sang-Jin Pak
Chairman of the Supervisory Board: Wolfgang Kirsch
Registered Office: Bad Homburg, Germany
Commercial Register: Amtsgericht Bad Homburg - HRB 11654

###